Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2231 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2231 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Neurology
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
What is being tested: Real-world safety, effectiveness, and patient treatment experience with BRIUMVI® (ublituximab-xiiy), a CD20-targeting B-cell depleting monoclonal antibody, in patients with relapsing…
23 Sep 2026 NCT06433752
● Recruiting Phase II Oncology
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Treatment being tested: Triple combination of visugromab (anti-VEGF-C monoclonal antibody), nivolumab (anti-PD-1), and lenvatinib (tyrosine kinase inhibitor) versus lenvatinib monotherapy plus placebo in treatment-resistant…
23 Sep 2026 NCT07219459
● Recruiting Phase III Respiratory / COPD / Asthma
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Treatment being tested: Nerandomilast, a novel therapeutic agent, is being investigated for its efficacy in slowing disease progression in fibrosing interstitial lung disease (excluding…
23 Sep 2026 NCT07540988
● Recruiting Cardiology / Cardiovascular
Delivery and Implementation of a Randomised Crossover Trial on Thrombosis
What is being tested: The DIRECT study evaluates optimal prevention strategies for thrombosis (blood clots) in patients with hip fractures through a randomised crossover…
23 Sep 2026 NCT06937372
● Recruiting Cardiology / Cardiovascular
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
What is being tested: Orbital atherectomy (OA), a minimally invasive procedure using a small spinning device for plaque removal, is being evaluated in real-world…
23 Sep 2026 NCT07270562
● Recruiting Cardiology / Cardiovascular
REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia
What is being tested: Esprit BTK™ Everolimus Eluting Resorbable Scaffolds are being evaluated in a European multicentre study of 400 patients to assess their…
23 Sep 2026 NCT07270575
● Recruiting Phase I / Phase II
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Single eye injection of SAR446597 tested for safety and effectiveness in age-related macular degeneration vision loss over two years.
22 Sep 2026 NCT07215234
● Recruiting Phase I
A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants
Phenytoin and itraconazole significantly alter pelabresib blood levels; phenytoin reduces levels while itraconazole increases them in healthy volunteers.
22 Sep 2026 NCT07783503
active not recruiting Phase II
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
Iptacopan tested to prevent progression of early-to-intermediate age-related macular degeneration to advanced vision loss.
22 Sep 2026 NCT05230537
● Recruiting Respiratory / COPD / Asthma
N-WATCH: Nottingham Wheeze Assessment in Tidal Children
What is being tested: N-WATCH evaluates novel tidal breathing techniques for improved diagnosis and monitoring of long-term paediatric lung diseases, particularly asthma, as an…
22 Sep 2026 NCT07833826
● Recruiting Oncology
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Intervention tested: An EPA-enriched (eicosapentaenoic acid) nutritional intervention is being evaluated in a randomised controlled trial to address malnutrition in cancer patients, with the…
22 Sep 2026 NCT07255066
● Recruiting Gastroenterology
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
What is being tested: The DIALIVE 2.0 liver dialysis device, an extracorporeal liver support system designed to be used alongside standard care in patients…
22 Sep 2026 NCT07347275
● Recruiting Phase III Diabetes / Metabolic
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Treatment being tested: AZD6234, a novel investigational agent, is being evaluated for its efficacy and safety in reducing body weight compared to placebo over…
22 Sep 2026 NCT07784270
● Recruiting Cardiology / Cardiovascular
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
What is being tested: Catheter ablation with pulmonary vein isolation compared to DC cardioversion alone in patients with persistent atrial fibrillation, measuring AF recurrence…
22 Sep 2026 NCT06096246
● Recruiting Cardiology / Cardiovascular
A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI)
What is being tested: The study evaluates whether pre-procedure CT scans and transthoracic echocardiography (TTE) can accurately predict outcomes and guide patient selection for…
22 Sep 2026 NCT06596460
● Recruiting Phase III Oncology
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
What is being tested: Setidegrasib, a KRAS inhibitor, combined with either mFOLFIRINOX or NALIRIFOX chemotherapy regimens in patients with metastatic pancreatic cancer to evaluate…
22 Sep 2026 NCT07409272
active not recruiting Phase III
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Erenumab reduced monthly migraine days more than placebo in children and teenagers aged 6-17 with episodic migraines.
21 Sep 2026 NCT03836040
active not recruiting Phase III Rheumatology
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Trial testing JNJ-77242113 against placebo and deucravacitinib for moderate to severe plaque psoriasis effectiveness.
21 Sep 2026 NCT06143878
● Recruiting Phase III Rare Diseases
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
Gene therapy for inherited eye disease causing vision loss in males, testing safety and effectiveness in children and adults.
21 Sep 2026 NCT05878860
active not recruiting Phase I / Phase II Oncology
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
Early-stage trial testing whether AZD5305 PARP inhibitor works alone or combined with other cancer drugs in advanced solid tumors.
21 Sep 2026 NCT04644068
● Recruiting Phase II Cardiology / Cardiovascular
A-TANGO Phase 2 Study
What is being tested: A combination therapy of TAK-242 (a TLR4 antagonist) plus G-CSF (granulocyte-colony stimulating factor) added to standard ACLF treatment, compared to…
21 Sep 2026 NCT06890039
● Recruiting Respiratory / COPD / Asthma
Procedural Skills Transfer in Bronchoscopy
What is being tested: This feasibility study captures bronchoscopy procedural data (CT scans and endoscopy videos) from patients and bronchoscopists over three years to…
21 Sep 2026 NCT07168408
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Treatment being tested: Lunsekimig, a novel therapeutic agent being evaluated for long-term safety and efficacy in adults with eosinophilic COPD that remains inadequately controlled…
21 Sep 2026 NCT07793409
● Recruiting Cardiology / Cardiovascular
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
What is being tested: SALTIRE is investigating the underlying mechanisms driving aortic stenosis progression and post-valve replacement outcomes through longitudinal imaging (echocardiography every 6…
21 Sep 2026 NCT06047561
● Recruiting Phase II Cardiology / Cardiovascular
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
What is being tested: JX10, a novel therapeutic agent, is being evaluated against placebo in acute ischemic stroke patients to assess its safety and…
21 Sep 2026 NCT06990867
● Recruiting Oncology
Pre-Clinical Validation of ChemoINTEL Unified Algorithm Chemotherapeutic Response Prediction in Patients With Colorectal Cancer
What is being tested: The ChemoINTEL assay, which measures in vitro cytotoxic drug-induced apoptosis and cell death in fresh colorectal cancer tumour cells to…
21 Sep 2026 NCT07830407
active not recruiting
A Clinical Study on Acuris™ – Conometric Concept for Single Tooth Restoration
New friction-based crown system (Acuris) for single tooth implants shows good survival rates at one year without cement or screws.
18 Sep 2026 NCT04063878
active not recruiting Gastroenterology
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
Study measuring antibody and biomarker levels in blood of adults with late-onset Pompe disease to assess gene therapy readiness.
18 Sep 2026 NCT06150820
● Recruiting Phase I
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Trial testing whether new medicine Inno8 is safe and effective at different doses for haemophilia A patients.
18 Sep 2026 NCT07220564
● Recruiting Phase III
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Elritercept versus epoetin alfa for reducing blood transfusion needs in low-risk myelodysplastic syndrome anaemia.
18 Sep 2026 NCT07422480
● Recruiting Phase I Gastroenterology
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body’s Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Early trial testing whether afimkibart affects how the body breaks down common medicines in ulcerative colitis patients.
18 Sep 2026 NCT07665723
● Recruiting
Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients
Restricting non-resuscitation fluids in septic shock patients may improve outcomes compared to standard fluid management.
18 Sep 2026 NCT06140147
● Recruiting Cardiology / Cardiovascular
Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn’s Disease
What is being tested: Fibrosis-associated protein inhibitor (FAPI) radiotracer imaging as a novel diagnostic tool to identify and characterise fibrotic strictures in Crohn's Disease…
18 Sep 2026 NCT07152431
● Recruiting Diabetes / Metabolic
Benefits of Retained Insulin for Good Health
What is being tested: The clinical impact of retained endogenous insulin production (measured by C-peptide levels) on quality of life and health outcomes in…
18 Sep 2026 NCT07828626
● Recruiting Cardiology / Cardiovascular
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
What is being tested: Manganese-enhanced MRI imaging to investigate the physiological mechanisms of takotsubo cardiomyopathy (broken heart syndrome) and evaluate how different cardiac medications…
18 Sep 2026 NCT07491718
● Recruiting Cardiology / Cardiovascular
Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging
What is being tested: Novel imaging techniques to characterise inflammation, microcalcification, and thrombus activity within atherosclerotic plaques across peripheral and systemic vascular territories in…
18 Sep 2026 NCT07472049
● Recruiting Phase II Oncology
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
What is being tested: Long-term safety and efficacy outcomes in pediatric and adult patients previously treated with gene-modified T-cell therapy through Celgene-sponsored clinical trials,…
18 Sep 2026 NCT03435796
● Recruiting Phase II Oncology
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
What is being tested: MEN1703 (SEL24/Dapolsertib hydrochloride), a novel agent being evaluated as monotherapy or in combination with glofitamab, assessing safety and anti-lymphoma activity…
18 Sep 2026 NCT06534437
● Recruiting Phase II / Phase III Infectious Disease
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
PLG0206 tested as wound irrigation during knee implant infection surgery to prevent reinfection and improve outcomes.
17 Sep 2026 NCT07214311
● Recruiting
Tolerance in Beekeepers
Researchers investigate why some bee-sensitized beekeepers develop severe allergic reactions to stings while others remain protected.
17 Sep 2026 NCT06156046
active not recruiting Phase III
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Elamipretide daily injections slow photoreceptor loss in dry age-related macular degeneration compared with placebo.
17 Sep 2026 NCT06373731
● Recruiting Gastroenterology
Achilles Tendon Rupture Patient Outcomes at 12 Months
Study evaluates strength recovery and function 12-15 months after non-surgical Achilles tendon rupture treatment using the SMART protocol.
17 Sep 2026 NCT07391553
● Recruiting Infectious Disease
Exactech Shoulder Post Market Clinical Follow-up Study
Long-term safety and performance study of Exactech shoulder replacements, following patients for at least 10 years.
17 Sep 2026 NCT05603728
● Recruiting Phase III
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
Long-term safety and effectiveness of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal haemoglobinuria.
17 Sep 2026 NCT05744921
● Recruiting Diabetes / Metabolic
Weight and Metabolic Management Study
A 16-week study testing whether a nutritional supplement helps adults lose weight or prevent regain after stopping GLP-1 medications.
17 Sep 2026 NCT07789223
● Recruiting Respiratory / COPD / Asthma
A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma
What is being tested: Concordance between international asthma diagnostic guidelines and evaluation of additional non-guideline physiologic measures (impulse oscillometry/IOS) to detect airways disease beyond…
17 Sep 2026 NCT06286085
● Recruiting Oncology
Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)
What is being tested: The study evaluates whether breast biomechanics can be reliably measured and assessed in women who have undergone breast cancer treatment…
17 Sep 2026 NCT07135960
● Recruiting Oncology
Identification of B Regulatory Cells by Flow Cytometry
What is being tested: Development and validation of a flow cytometry-based test to quantify B-regulatory cells (Bregs) in blood samples from allergic patients undergoing…
17 Sep 2026 NCT06876506
● Recruiting Phase III Cardiology / Cardiovascular
Low INR to Minimize Bleeding With Mechanical Valves Trial
What is being tested: The safety and efficacy of a lower INR target range (1.5-2.5) compared to standard anticoagulation in patients with mechanical bileaflet…
17 Sep 2026 NCT03636295
● Recruiting Cardiology / Cardiovascular
Zenith® Fenestrated+ Clinical Study
What is being tested: Safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) combined with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System…
17 Sep 2026 NCT04875429